Oncotype DX vs Freenome

Side-by-side comparison of cancer screening tests.

← Back to Cancer Screening

Oncotype DX

Guideline recommended
Variable

Breast recurrence risk

Freenome

FDA approved
Variable

Colorectal only

Test Performance

FeatureOncotype DXFreenome
PriceVariableVariable
Cancers DetectedBreast recurrence riskColorectal only
SensitivityN/A81.1% for CRC
SpecificityN/A90.4%
Sample TypeTumor tissueBlood draw
FDA StatusGuideline recommendedFDA approved

Get monthly price updates &deals

We track pricing changes across 50+ health testing providers so you don't have to.

Free, once a month. No spam.